Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).
While the spikes that are characteristic of COVID-19 are well-documented, researchers have detected a subtle change from the onset of the pandemic in January to May, when the virus ultimately engulfed New York City.
The American Medical Association, American Hospital Association and American Nurses Association on Monday urged Americans to wear a mask and practice social distancing in an effort to stem the spread of the coronavirus.
The ViewPoints Series is an interactive learning module featuring leading industry experts from across the eyecare spectrum. The series leverages the various perspectives of panel participants to create a meaningful conversation on a range of eye health topics and issues related to current clinical data and industry trends.
In a new survey by medical software provider Kyruus, nearly three quarters had tried virtual care during the COVID-19 pandemic and more than 75 percent said they were very or completely satisfied with their experience.
According to the Centers for Disease Control, coronavirus cases are on the rise in at least 32 states, and many of these states are also seeing increasing hospitalizations. These numbers are raising a red flag among ophthalmologists.